Table of Contents
Executive Summary
1 Industry Overview of Alzheimer’s Pipeline Drugs
1.1 Definition of Alzheimer’s Pipeline Drugs
1.2 Alzheimer’s Pipeline Drugs Segment by Type
1.2.1 Global Alzheimer’s Pipeline Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Namenda
1.2.3 Ebixa
1.2.4 Axura
1.2.5 Aricept
1.2.6 Nootropil
1.2.7 Exelon
1.2.8 Memary
1.2.9 Solanezumab
1.2.10 LuAe58054
1.3 Alzheimer’s Pipeline Drugs Segment by Applications
1.3.1 Global Alzheimer’s Pipeline Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Alzheimer’s Pipeline Drugs Overall Market
1.4.1 Global Alzheimer’s Pipeline Drugs Revenue (2014-2025)
1.4.2 Global Alzheimer’s Pipeline Drugs Production (2014-2025)
1.4.3 North America Alzheimer’s Pipeline Drugs Status and Prospect (2014-2025)
1.4.4 Europe Alzheimer’s Pipeline Drugs Status and Prospect (2014-2025)
1.4.5 China Alzheimer’s Pipeline Drugs Status and Prospect (2014-2025)
1.4.6 Japan Alzheimer’s Pipeline Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Alzheimer’s Pipeline Drugs Status and Prospect (2014-2025)
1.4.8 India Alzheimer’s Pipeline Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Alzheimer’s Pipeline Drugs
2.3 Manufacturing Process Analysis of Alzheimer’s Pipeline Drugs
2.4 Industry Chain Structure of Alzheimer’s Pipeline Drugs
3 Development and Manufacturing Plants Analysis of Alzheimer’s Pipeline Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Alzheimer’s Pipeline Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Alzheimer’s Pipeline Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Alzheimer’s Pipeline Drugs Production and Capacity Analysis
4.2 Alzheimer’s Pipeline Drugs Revenue Analysis
4.3 Alzheimer’s Pipeline Drugs Price Analysis
4.4 Market Concentration Degree
5 Alzheimer’s Pipeline Drugs Regional Market Analysis
5.1 Alzheimer’s Pipeline Drugs Production by Regions
5.1.1 Global Alzheimer’s Pipeline Drugs Production by Regions
5.1.2 Global Alzheimer’s Pipeline Drugs Revenue by Regions
5.2 Alzheimer’s Pipeline Drugs Consumption by Regions
5.3 North America Alzheimer’s Pipeline Drugs Market Analysis
5.3.1 North America Alzheimer’s Pipeline Drugs Production
5.3.2 North America Alzheimer’s Pipeline Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Alzheimer’s Pipeline Drugs Import and Export
5.4 Europe Alzheimer’s Pipeline Drugs Market Analysis
5.4.1 Europe Alzheimer’s Pipeline Drugs Production
5.4.2 Europe Alzheimer’s Pipeline Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Alzheimer’s Pipeline Drugs Import and Export
5.5 China Alzheimer’s Pipeline Drugs Market Analysis
5.5.1 China Alzheimer’s Pipeline Drugs Production
5.5.2 China Alzheimer’s Pipeline Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Alzheimer’s Pipeline Drugs Import and Export
5.6 Japan Alzheimer’s Pipeline Drugs Market Analysis
5.6.1 Japan Alzheimer’s Pipeline Drugs Production
5.6.2 Japan Alzheimer’s Pipeline Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Alzheimer’s Pipeline Drugs Import and Export
5.7 Southeast Asia Alzheimer’s Pipeline Drugs Market Analysis
5.7.1 Southeast Asia Alzheimer’s Pipeline Drugs Production
5.7.2 Southeast Asia Alzheimer’s Pipeline Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Alzheimer’s Pipeline Drugs Import and Export
5.8 India Alzheimer’s Pipeline Drugs Market Analysis
5.8.1 India Alzheimer’s Pipeline Drugs Production
5.8.2 India Alzheimer’s Pipeline Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Alzheimer’s Pipeline Drugs Import and Export
6 Alzheimer’s Pipeline Drugs Segment Market Analysis (by Type)
6.1 Global Alzheimer’s Pipeline Drugs Production by Type
6.2 Global Alzheimer’s Pipeline Drugs Revenue by Type
6.3 Alzheimer’s Pipeline Drugs Price by Type
7 Alzheimer’s Pipeline Drugs Segment Market Analysis (by Application)
7.1 Global Alzheimer’s Pipeline Drugs Consumption by Application
7.2 Global Alzheimer’s Pipeline Drugs Consumption Market Share by Application (2014-2019)
8 Alzheimer’s Pipeline Drugs Major Manufacturers Analysis
8.1 Forest Laboratorie
8.1.1 Forest Laboratorie Alzheimer’s Pipeline Drugs Production Sites and Area Served
8.1.2 Forest Laboratorie Product Introduction, Application and Specification
8.1.3 Forest Laboratorie Alzheimer’s Pipeline Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eisai
8.2.1 Eisai Alzheimer’s Pipeline Drugs Production Sites and Area Served
8.2.2 Eisai Product Introduction, Application and Specification
8.2.3 Eisai Alzheimer’s Pipeline Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 H. Lundbeck A/S
8.3.1 H. Lundbeck A/S Alzheimer’s Pipeline Drugs Production Sites and Area Served
8.3.2 H. Lundbeck A/S Product Introduction, Application and Specification
8.3.3 H. Lundbeck A/S Alzheimer’s Pipeline Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis
8.4.1 Novartis Alzheimer’s Pipeline Drugs Production Sites and Area Served
8.4.2 Novartis Product Introduction, Application and Specification
8.4.3 Novartis Alzheimer’s Pipeline Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Merz GmbH & Co. KGaA
8.5.1 Merz GmbH & Co. KGaA Alzheimer’s Pipeline Drugs Production Sites and Area Served
8.5.2 Merz GmbH & Co. KGaA Product Introduction, Application and Specification
8.5.3 Merz GmbH & Co. KGaA Alzheimer’s Pipeline Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Alzheimer’s Pipeline Drugs Production Sites and Area Served
8.6.2 Johnson & Johnson Product Introduction, Application and Specification
8.6.3 Johnson & Johnson Alzheimer’s Pipeline Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 UCB
8.7.1 UCB Alzheimer’s Pipeline Drugs Production Sites and Area Served
8.7.2 UCB Product Introduction, Application and Specification
8.7.3 UCB Alzheimer’s Pipeline Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Alzheimer’s Pipeline Drugs Market
9.1 Global Alzheimer’s Pipeline Drugs Market Trend Analysis
9.1.1 Global Alzheimer’s Pipeline Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Alzheimer’s Pipeline Drugs Regional Market Trend
9.2.1 North America Alzheimer’s Pipeline Drugs Forecast 2019-2025
9.2.2 Europe Alzheimer’s Pipeline Drugs Forecast 2019-2025
9.2.3 China Alzheimer’s Pipeline Drugs Forecast 2019-2025
9.2.4 Japan Alzheimer’s Pipeline Drugs Forecast 2019-2025
9.2.5 Southeast Asia Alzheimer’s Pipeline Drugs Forecast 2019-2025
9.2.6 India Alzheimer’s Pipeline Drugs Forecast 2019-2025
9.3 Alzheimer’s Pipeline Drugs Market Trend (Product Type)
9.4 Alzheimer’s Pipeline Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Alzheimer’s Pipeline Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
【掲載企業】
Forest Laboratorie、Eisai、H. Lundbeck A/S、Novartis、Merz GmbH & Co. KGaA、Johnson & Johnson、UCB